Skip Navigation

Defense Health Agency

"On October 1, 2013, the Department of Defense established the Defense Health Agency (DHA) to manage the activities of the Military Health System. These activities include those previously managed by TRICARE Management Activity (TMA), which was disestablished on the same date. During the next several months, all TMA websites will change to reflect the new DHA. We appreciate your patience during this transition."
 


Drug Class UF BPA Appendix UF VARR Appendix
DIABETES: NON-INSULIN: Subclass: Amylin Agonist  Click Here  Click Here
DIABETES: NON-INSULIN: Subclass: Alpha-Glucosidase Inhibitors  Click Here  Click Here
DIABETES: NON-INSULIN: Subclass: Biguanides  Click Here  Click Here
DIABETES: NON-INSULIN: Subclass: Dipeptidyl Peptidase 4 (DPP-4) Inhibitors  Click Here  Click Here
DIABETES: NON-INSULIN: Subclass: Glucagon-like peptide-1 (GLP-1) Receptor Agonists  Click Here  Click Here
DIABETES: NON-INSULIN: Subclass: Meglitinides  Click Here  Click Here
DIABETES: NON-INSULIN: Subclass: Thiazolidinediones  Click Here  Click Here
Designated Newly Approved Drugs